复发头颈部鳞状细胞癌挽救性手术及术后IMRT再程放疗后的失败模式
本研究评估61例连续接受挽救性手术及术后IMRT再程放疗(≥60 Gy)的复发头颈部鳞状细胞癌患者的局部区域复发模式,采用医师视觉分类与可变形图像配准(DIR)两种方法判定,55例可分析者中23例(42%)出现局部区域复发,原复发部位为淋巴者挽救率为67%而黏膜者为33%(p=0.037)。
要点
- 55例可分析患者中23例(42%)出现局部区域复发。
- 原复发部位为淋巴者挽救率67%,黏膜者为33%(p=0.037)。
- 医师分类与DIR判定的复发分布存在差异,DIR可减少观察者间变异。
核心结论
- DIR有助于提高失败模式分析的准确性与一致性,较传统视觉判读减少观察者间变异。
- 原复发部位是挽救性手术及再程IMRT后局部区域复发的关键预测因素。
研究设计与样本
- 2003年至2014年连续治疗的61例复发头颈部鳞状细胞癌患者,接受术后IMRT再程放疗剂量≥60 Gy。
- 采用医师视觉比较与可变形图像配准(DIR)两种方法判定局部区域复发模式。
- 排除无可评估CT计划图像数据者,最终55例纳入分析。
- 所有复发均经活检或影像学进展证实。
主要发现
- 55例可分析患者中23例(42%)记录到局部区域复发。
- 原复发部位为淋巴者挽救率为67%,黏膜部位者为33%(p=0.037)。
- 医师分类判定:野内失败14例(61%),边缘失败3例(13%),野外失败6例(26%)。
- DIR判定:野内失败10例(44%),边缘失败4例(17%),野外失败9例(39%)。
- 多数失败(57%)发生于原复发部位或第一站淋巴引流区;挽救性手术中放置游离皮瓣者中56%的失败发生在手术皮瓣1 cm范围内。
关键数值与推荐
- 再程放疗剂量为术后IMRT≥60 Gy。
- 原复发部位(淋巴 vs 黏膜)与局部区域复发的关联:淋巴部位挽救率67% vs 黏膜部位33%(p=0.037)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE/OBJECTIVES: The purpose of this study was to evaluate patterns of locoregional recurrence (LRR) after surgical salvage and adjuvant reirradiation with IMRT for recurrent head and neck squamous cell cancer (HNSCC). MATERIALS/METHODS: Patterns of LRR for 61 patients treated consecutively between 2003 and 2014 who received post-operative IMRT reirradiation to ≥ 60 Gy for recurrent HNSCC were determined by 2 methods: 1) physician classification via visual comparison of post-radiotherapy imaging to reirradiation plans; and 2) using deformable image registration (DIR). Those without evaluable CT planning image data were excluded. All recurrences were verified by biopsy or radiological progression. Failures were defined as in-field, marginal, or out-of-field. Logistic regression analyses were performed to identify predictors for LRR. RESULTS: A total of 55 patients were eligible for analysis and 23 (42 %) had documented LRR after reirradiation. Location of recurrent disease prior to salvage surgery (lymphatic vs. mucosal) was the most significant predictor of LRR after post-operative reirradiation with salvage rate of 67 % for lymphatic vs. 33 % for mucosal sites (p = 0.037). Physician classification of LRR yielded 14 (61 %) in-field failures, 3 (13 %) marginal failures, and 6 (26 %) out-of-field failures, while DIR yielded 10 (44 %) in-field failures, 4 (17 %) marginal failures, and 9 (39 %) out-of-field failures. Most failures (57 %) occurred within the original site of recurrence or first echelon lymphatic drainage. Of patients who had a free flap placed during salvage surgery, 56 % of failures occurred within 1 cm of the surgical flap. CONCLUSION: Our study highlights the role of DIR in enhancing the accuracy and consistency of POF analysis. Compared to traditional visual inspection, DIR reduces interobserver variability and provides more nuanced insights into dose-specific and spatial parameters of locoregional recurrences. Additionally, the study identifies the location of the initial recurrence as a key predictor of subsequent locoregional recurrence after salvage surgery and re-IMRT.
引用
- Mohamed ASR, Martin GV, Ng SP, et al. Patterns of failure for recurrent head and neck squamous cell carcinoma treated with salvage surgery and postoperative IMRT reirradiation. Clin Transl Radiat Oncol. 2023. PMID: 38058404. doi:10.1016/j.ctro.2023.100700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。